Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics

M Adamaki, V Zoumpourlis - Pharmacology & therapeutics, 2021 - Elsevier
Prostate cancer (PCa) is one of the most commonly diagnosed malignancies and among the
leading causes of cancer-related death worldwide. It is a highly heterogeneous disease …

Targeted radionuclide therapy of prostate cancer—from basic research to clinical perspectives

M Czerwińska, A Bilewicz, M Kruszewski… - Molecules, 2020 - mdpi.com
Prostate cancer is the most commonly diagnosed malignancy in men and the second
leading cause of cancer-related deaths in Western civilization. Although localized prostate …

Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study

H Kübler, B Scheel, U Gnad-Vogt, K Miller… - … for immunotherapy of …, 2015 - Springer
Background CV9103 is a prostate-cancer vaccine containing self-adjuvanted mRNA
(RNActive®) encoding the antigens PSA, PSCA, PSMA, and STEAP1. This phase I/IIa study …

Identification of distinct populations of prostasomes that differentially express prostate stem cell antigen, annexin A1, and GLIPR2 in humans

M Aalberts, FMF van Dissel-Emiliani… - Biology of …, 2012 - academic.oup.com
In addition to sperm cells, seminal fluid contains various small membranous vesicles. These
include prostasomes, membrane vesicles secreted by prostate epithelial cells. Prostasomes …

[HTML][HTML] Retargeting of T lymphocytes to PSCA-or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “ …

A Feldmann, C Arndt, R Bergmann, S Loff… - Oncotarget, 2017 - ncbi.nlm.nih.gov
New treatment options especially of solid tumors including for metastasized prostate cancer
(PCa) are urgently needed. Recent treatments of leukemias with chimeric antigen receptors …

Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution

GE Duclos, VH Teixeira, P Autissier, YB Gesthalter… - Science …, 2019 - science.org
The human bronchial epithelium is composed of multiple distinct cell types that cooperate to
defend against environmental insults. While studies have shown that smoking alters …

[HTML][HTML] Fabrication of antibody conjugated super magnetic oxide nanoparticles for early detection of prostate cancer

D Jafari-Gharabaghlou, MFS Jadid… - Asian Pacific Journal …, 2023 - ncbi.nlm.nih.gov
Background: Prostate cancer is one of the most widespread cancers in the world. Early
diagnosis is the most important factor in treatment efficiency. Furthermore, new methods for …

A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population

C Tanikawa, Y Urabe, K Matsuo, M Kubo… - Nature …, 2012 - nature.com
Through a genome-wide association analysis with a total of 7,035 individuals with duodenal
ulcer and 25,323 controls from Japan, we identified two susceptibility loci at the PSCA gene …

Bispecific T-Cell engagers therapies in solid tumors: focusing on prostate cancer

DC Simão, KK Zarrabi, JL Mendes, R Luz, JA Garcia… - Cancers, 2023 - mdpi.com
Simple Summary Cancer treatments have significantly changed with the introduction of
immunotherapy. Recently, the development of new agents that harness the redirection of T …

Prostate cancer relevant antigens and enzymes for targeted drug delivery

A Barve, W Jin, K Cheng - Journal of Controlled Release, 2014 - Elsevier
Chemotherapy is one of the most widely used approaches in combating advanced prostate
cancer, but its therapeutic efficacy is usually insufficient due to poor specificity and …